Drug Master Files for: NICOTINE POLACRILEX
✉ Email this page to a colleague
NICOTINE POLACRILEX Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
10527 | I | II | 8/31/1993 | FINE CHEMICALS CORP | NICOTINE POLACRILEX |
10634 | I | II | 12/15/1993 | PHARMACIA AND UPJOHN | MANUFACTURING SITE, FACILITIES, PERSONNLE, AND GENERAL OPERATING PROCEDURES OF NICOTINE CONTAINING PRODUCTS IN HELSINGBORG, SWEDEN. |
10739 | A | II | 2/1/1994 | NICOBRAND LTD | NICOTINE POLACRILEX RESIN |
12584 | I | II | 7/11/1997 | NICOBRAND LTD | NICOTINE BITARTRATE DIHYDRATE |
13015 | I | II | 6/10/1998 | MCNEIL CONSUMER HEALTHCARE | NICOTINE PURIFICATION PROCESS |
14193 | I | II | 5/7/1999 | SALSBURY CHEMICALS INC | NICOTINE POLACRILEX RESIN |
16166 | A | II | 10/1/2002 | CAMBREX CHARLES CITY INC | NICOTINE POLACRILEX, 15%, USP |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information